Hemifacial spasm: Clinical findings and treatment
Anchi Wang MD
Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, 6550 Fannin, Suite 1801, Houston, Texas 77030, USA
Search for more papers by this authorCorresponding Author
Joseph Jankovic MD
Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, 6550 Fannin, Suite 1801, Houston, Texas 77030, USA
Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, 6550 Fannin, Suite 1801, Houston, Texas 77030, USASearch for more papers by this authorAnchi Wang MD
Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, 6550 Fannin, Suite 1801, Houston, Texas 77030, USA
Search for more papers by this authorCorresponding Author
Joseph Jankovic MD
Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, 6550 Fannin, Suite 1801, Houston, Texas 77030, USA
Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, 6550 Fannin, Suite 1801, Houston, Texas 77030, USASearch for more papers by this authorAbstract
Hemifacial spasm (HFS) is a peripherally induced movement disorder characterized by involuntary, unilateral, intermittent, irregular, tonic or clonic contractions of muscles innervated by the ipsilateral facial nerve. We reviewed the clinical features and response to different treatments in 158 patients (61% women) with HFS evaluated at our Movement Disorders Clinic. The mean age at onset was 48.5 ± 14.1 years (range: 15–87) and the mean duration of symptoms was 11.4 ± 8.5 (range: 0.5–53) years. The left side was affected in 56% instances; 5 patients had bilateral HFS. The lower lid was the most common site of the initial involvement followed by cheek and perioral region. Involuntary eye closure which interfered with vision and social embarrassment were the most common complaints. HFS was associated with trigeminal neuralgia in 5.1% of the cases and 5.7% had prior history of Bell's palsy. Although vascular abnormalities, facial nerve injury, and intracranial tumor were responsible for symptoms in some patients, most patients had no apparent etiology. Botulinum toxin type A(BTX-A)injections, used in 110 patients, provided marked to moderate improvement in 95% of patients. Seven of the 25 (28%) patients who had microvascular decompression reported permanent complications and the HFS recurred in 5 (20%). Although occasionally troublesome, HFS is generally a benign disorder that can be treated effectively with either BTX-A or microvascular decompression. © 1998 John Wiley & Sons, Inc. Muscle Nerve 21: 1740–1747, 1998
References
- 1 Adler CA, Zimmerman RA, Savino PJ, Bernardi B, Bosley TM, Sergott RC: Hemifacial spasm: evaluation by magnetic resonance imaging and magnetic resonance tomographic angiography. Ann Neurol 1992; 32: 502–506.
- 2 Ainsworth JR, Kraft SP: Longterm changes in duration of relief with botulinum toxin treatment for essential blepharospasm and hemifacial spasm. Ophthalmology 1995; 102: 2036–2040.
- 3 Alexander GE, Moses H: Carbamazepine for hemifacial spasm. Neurology 1982; 32: 286–287.
- 4 Ambrosetto P, Forlani S: Lacune pontine infarction presenting as isolated hemifacial spasm. Stroke 1988; 19: 784–785.
- 5 Astarloa R, Morales B, Penafiel N, Rbano J, de Yebenes JG: Craniocervical dystonia and facial hemispasm: clinical and pharmacological characteristics of 52 patients. Rev Clin Esp 1991; 189: 320–324.
- 6 Auger RG: Hemifacial spasm: clinical and electrophysiologic observations. Neurology 1979; 29: 1261–1272.
- 7 Auger RG, Piepgras DG: Hemifacial spasm associated with epidermoid tumor of the cerebellopontine angle. Neurology 1989; 39: 577–580.
- 8 Auger RG, Piepgras DG, Laws ER, Miller RH: Microvascular decompression of the facial nerve for hemifacial spasm: clinical and electrophysiologic observations. Neurology 1981; 31: 346–350.
- 9 Auger RG, Piepgras DG, Laws ER: Hemifacial spasm: results of microvascular decompression of the facial nerve in 54 patients. Mayo Clin Proc 1986; 61: 640–644.
- 10 Auger RG, Litchy WJ, Cascino TL, et al.: Hemimasticatory spasm: clinical and electrophysiologic observations. Neurology 1992; 42: 2263–2266.
- 11 Barker FG, Jannetta PJ, Bissonette DJ, Shields PT, Larkins MV, Jho HD: Microvascular decompression for hemifacial spasm. J Neurosurg 1995; 82: 201–210.
- 12 Bauer AC, Coker NJ: Update on facial nerve disorders. Otolaryngol Clin North Am 1996; 29: 445–454.
- 13 Bills DC, Hanieh A: Hemifacial spasm in an infant due to fourth ventricular ganglioglioma. J Neurosurg 1991; 75: 134–137.
- 14 Campbell E, Keedy C: Hemifacial spasm: a note on the etiology in two cases. J Neurosurg 1947; 4: 342–347.
- 15 Carter JB, Patrinely JR, Jankovic J, McCrary J, Boniuk M: Familial hemifacial spasm. Arch Ophthalmol 1990; 108: 249–250.
- 16 Chang CG, Cho DY, Lee JC, Yang DY: Intracranial meningiomas: 5 year analysis. Chung Hua I Hsueh Tsa Chih(Taipei) 1989; 43: 321–330.
- 17 Chen HJ, Lee TC, Liu CC: Hemifacial spasm caused by a venous angioma. J Neurosurg 1996; 85: 716–717.
- 18 Coad JE, Wirtschafter JD, Haines SJ, et al.: Familial hemifacial spasm associated with arterial compression of the facial nerve. J Neurosurg 1991; 74: 290–296.
- 19 Cockerell OC, Rothwell J, Thompson PD, et al.: Clinical and physiological features of epilepsia partialis continua: cases ascertained in the UK. Brain 1996; 119: 393–407.
- 20 Cushing H: The major trigeminal neuralgias and their surgical treatment based on experience with 332 gasserian operations. The varieties of facial neuralgia. Am J Med Sci 1920; 160: 157–185.
- 21 Digre K, Corbett JJ: Hemifacial spasm: differential diagnosis, mechanism, and treatment. Adv Neurol 1988; 49: 151–176.
- 22 Digre KB, Corbett JJ, Smoker WRK, McKusker S: CT and hemifacial spasm. Neurology 1988; 38: 1111–1113.
- 23 Dutton JJ: Botulinum-A toxin in the treatment of craniocervical muscle spasm: short- and long-term local and systemic effects. Surv Ophthalmol 1996; 41: 51–65.
- 24 Dutton JJ, Buckley EG: Botulinum toxin in the management of blepharospasm. Arch Neurol 1986; 43: 380–382.
- 25 Eby TL, Fisch U, Makek MS: Facial nerve management in temporal bone hemangiomas. Am J Otol 1992; 13: 223–232.
- 26 Ehni G, Woltman HW: Hemifacial spasm. Arch Neurol Psychiatry 1945; 53: 205–211.
- 27 Elston JS: The management of blepharospasm and hemifacial spasm. J Neurol 1992; 239: 5–8.
- 28 Estaban A, Molina-Negro P: Primary hemifacial spasm: a physiological study. J Neurol Neurosurg Psychiatry 1986; 49: 58–63.
- 29 Felber S, Birbamer G, Aichner E, Poewe W, Kampf L: Magnetic resonance imaging and angiography in hemifacial spasm. Neuroradiology 1992; 34: 413–416.
- 30 Flander M, Chin D, Boghen D: Botulinum toxin: preferred treatment for hemifacial spasm. Eur Neurol 1993; 33: 316–319.
- 31 Friedman A, Jamrozik Z, Bojakowski J: Familial hemifacial spasm. Mov Disord 1989; 4: 213–218.
- 32 Frueh BR, Preston RA, Musch DC: Facial nerve injury and hemifacial spasm. Am J Ophthalmol 1990; 110: 421–423.
- 33 Garland PE, Patrinely JR, Anderson RL: Hemifacial spasm. Results of unilateral myectomy. Ophthalmology 1987; 94: 288–294.
- 34 Gottlieb JS, May M: Blepharospasm-oromandibular dystonia (Meige's syndrome) misdiagnosed as secondary hemifacial spasm. Am J Otol 1984; 5: 206–210.
- 35 Hanakita J, Kondo A: Serious complications of microvascular decompression operations for trigeminal neuralgia and hemifacial spasm. Neurosurgery 1988; 22: 348–352.
- 36 Harsh GR, Wilson CB, Hieshima GB, Dillon WP: Magnetic resonance imaging of vertebrobasilar ectasia in tic convulsif. J Neurosurg 1991; 74: 999–1003.
- 37 Holds JB, Anderson RL, Jordan DR, Patrinely JR: Bilateral hemifacial spasm. J Clin Neuro-Ophthal 1990; 10: 153–156.
- 38 Holds JB, White GL, Thiese SM, et al.: Facial dystonia, essential blepharospasm and hemifacial spasm. Am Fam Physician 1991; 43: 2113–2120.
- 39 Horowitz SH: Hemifacial spasm and facial myokymia: electro-physiological findings. Muscle Nerve 1987; 10: 422–427.
- 40 Huang C-I, Chen I-H, Lee L-S: Microvascular decompression for hemifacial spasm: analyses of operative findings and results in 310 patients. Neurosurgery 1992; 30: 53–57.
- 41 Illingworth RD, Porter DG, Jakubowski J: Hemifacial spasm: a prospective long-term follow-up of 83 cases treated by microvascular decompression at two neurological centres in the United Kingdom. J Neurol Neurosurg Psychiatry 1996; 60: 72–77.
- 42 Inoue T, Maeyama R, Ogawa H: Hemifacial spasm resulting from cerebellopontine angle lipoma: case report. Neurosurgery 1995; 36: 846–850.
- 43 Jacobs L, Kaba S, Pullicino P: The lesion causing facial myokymia in multiple sclerosis. Arch Neurol 1994; 51: 1115–1119.
- 44 Janetta PJ: Cranial rhizopathies, in JR Youmans (ed): Neurological Surgery, 3rd ed. Philadelphia:W. B. Saunders, 1990, pp 4169–4182.
- 45 Janetta PJ, Abbasy M, Maroon JC, et al.: Etiology and definitive microsurgical treatment of hemifacial spasm. J Neurosurg 1977; 47: 321–328.
- 46 Jankovic J: Etiology and differential diagnosis of blepharospasm and oromandibular dystonia. Adv Neurol 1988; 49: 103–116.
- 47 Jankovic J: Phenomenology and classification of tics. Neurol Clin 1997; 15: 267–275.
- 48 Jankovic J, Schwartz K: Clinical correlates of response to botulinum toxin injections. Arch Neurol 1991; 48: 1253–1256.
- 49 Jankovic J, Schwartz K, Donovan DT: Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm. J Neurol Neurosurg Psychiatry 1990; 53: 633–639.
- 50 Kalra HK, Magoon EH: Side effects of the use of botulinum toxin for treatment of benign essential blepharospasm and hemifacial spasm. Ophthalmic Surg 1990; 21: 335–338.
- 51 Kondo A: Follow-up results of microvascular decompression in trigeminal neuralgia and hemifacial spasm. Neurosurgery 1997; 40: 46–51.
- 52 Kraft SP, Lang AE: Cranial dystonia, blepharospasm and hemifacial spasm: clinical features and treatment, including the use of botulinum toxin. Can Med Assoc J 1988; 139: 837–844.
- 53 Kudo A, Susuki M, Kudo N, Kuroda K, Ogawa A, Iwasaki Y: Schwannoma arising from the intermediate nerve and manifesting as hemifacial spasm. J Neurosurg 1996; 84: 277–279.
- 54 Kuroki A, Moller AR: Facial nerve demyelination and vascular compression are both needed to induce facial hyperactivity: a study in rats. Acta Neurochir 1994; 126: 149–157.
- 55 Laskawi R, Ellies M, Drobik C, Batz A: Botulinum toxin treatment in patients with hemifacial spasm. Eur Arch Otorhinolaryngol 1994; 251: 271–274.
- 56 Lees A: Facial mannerism and tics. Adv Neurol 1988; 49: 255–261.
- 57 Linskey ME, Jho HD, Jannetta PJ: Microvascular decompression for trigeminal neuralgia caused by vertebrobasilar compression. J Neurosurg 1994; 81: 1–9.
- 58 Martinelli P, Giuliani S, Ippoliti M: Hemifacial spasm due to peripheral injury of facial nerve: a nuclear syndrome. Mov Disord 1992; 7: 181–184.
- 59 Mastumoto K, Saijo T, Kuyama H, Asari S, Nishimoto A: Hemifacial spasm caused by a spontaneous dissecting aneurysm of the vertebral artery. Case report. J Neurosurg 1991; 74: 650–652.
- 60 Matsuura N, Kondo A: Trigeminal neuralgia and hemifacial spasm as false localizing signs in patients with a contralateral mass of the posterior cranial fossa. J Neurosurg 1996; 84: 1067–1071.
- 61 Maurice-Williams RS: Tic convulsif: the association of trigeminal neuralgia and hemifacial spasm. Postgrad Med J 1973; 49: 742–745.
- 62 Mauriello JA, Leone T, Dhillon S, Pakeman B, Mostafavi R, Yepez MX: Treatment choices of 119 patients with hemifacial spasm over 11 years. Clin Neurol Neurosurg 1996; 98: 213–216.
- 63 Mellick GA: Hemifacial spasm: successful treatment with felbamate. J Pain Symptom Manage 1995; 10: 392–395.
- 64 Micheli F, Scorticati MC, Gatto E, Cerosimo G, Adi H: Familial hemifacial spasm. Mov Disord 1994; 9: 330–332.
- 65 Moller AR, Jannetta PJ: On the origin of synkinesis in hemifacial spasm: result of intracranial recording. J Neurosurg 1984; 61: 569–576.
- 66 Moller AR, Jannetta PJ: Synkinesis in hemifacial spasm: result of recording intracranially from the facial nerve. Experientia 1985; 41: 415–417.
- 67 Moller AR, Jannetta PJ: Physiological abnormalities in hemifacial spasm studied during microvascular decompression operations. Exp Neurol 1986; 93: 584–600.
- 68 Moller MB, Moller AR: Loss of auditory function in microvascular decompression for hemifacial spasm. J Neurosurg 1985; 63: 17–20.
- 69 Monsterrat L, Benito M: Facial synkinesis and aberrant regeneration of facial nerve. Adv Neurol 1988; 49: 211–224.
- 70 Montagna P, Imbriaco A, Zucconi M, Liguori R: Hemifacial spasm in sleep. Neurology 1986; 36: 270–273.
- 71 Nagata S, Fujii K, Nomura T, Matsushima T, Fukui M, Yasumori K: Hemifacial spasm caused by CP angle AVM associated with ruptured aneurysm in the feeding artery: case report. Neurol Med Chir (Tokyo) 1991; 31: 406–409.
- 72 Nagata S, Matsushima T, Fujii K, Masashi F, Kuromatsu C: Hemifacial spasm due to tumor, aneurysm, or arteriovenous malformation. Surg Neurol 1992; 38: 204–209.
- 73 Nielsen VK: Pathophysiology of hemifacial spasm: I. Ephaptic transmission and ectopic excitation. Neurology 1984; 34: 418–426.
- 74 Nielsen VK: Electrophysiology of the facial nerve in hemifacial spasm: ectopic/ephaptic excitation. Muscle Nerve 1985; 8: 545–555.
- 75 Nishi T, Matsukado Y, Nagahiro S, Fukushima M, Koga K: Hemifacial spasm due to contralateral acoustic neuroma: case report. Neurology 1987; 37: 339–342.
- 76 Odkvist LM, Thuomas KA, Niklasson M: Macrovascular causes underlying otoneurological disterbances. Acta Otolaryngol 1995; 115: 145–148.
- 77 Ogale SB, Chopra S, Thakur S: Transtympanic facial nerve needling: a curative surgical option for hemifacial spasms. Acta Otolaryngol 1995; 115: 405–407.
- 78 Patel J, Naritoku DK: Gabapentin for the treatment of hemifacial spasm. Clin Neuropharmacol 1996; 19: 185–188.
- 79 Payner TD, Tew JM Jr: Recurrence of hemifacial spasm after microvascular decompression. Neurosurgery 1996; 38: 686–690.
- 80 Price J, O'Day J: Efficacy and side effects of botulinum toxin treatment for blepharospasm and hemifacial spasm. Aust NZJ Ophthalmol 1994; 22: 255–260.
- 81 Rana PV, Wadia RS: The Martin-Amat syndrome: an unusual facial synkinesia. J Neurol Neurosurg Psychiatry 1985; 48: 939–941.
- 82 Ravesi G, Medici D, Macaluso GM, Ventura P, Allegri A, Gemignani F: Unsual synkinetic movements between facial muscles and respiration in hemifacial spasm. Mov Disord 1994; 9: 451–454.
- 83 Rhee BA, Kim TS, Kim GK, Leem WL: Hemifacial spasm caused by cerebellopontine angle meningioma: case report. Neurosurgery 1995; 36: 393–395.
- 84 Rijntjes M, Tegenthoff M, Liepert J, et al.: Cortical reorganization in patients with facial palsy. Ann Neurol 1997; 41: 621–630.
- 85 Rosso ALZ, Mattos JP, Fogel LM: Bilateral hemifacial spasm. Mov Disord 1994; 9: 236–243.
- 86 Rushworth RG, Smith SF: Trigeminal neuralgia and hemifacial spasm. Med J Aust 1982; 1: 424–426.
- 87 Ruusuvaara P, Setala K: Long-term treatment of involuntary facial spasms using botulinum toxin. Acta Ophthalmol 1990; 68: 331–338.
- 88 Sanders DB: Ephaptic transmission in hemifacial spasm: a single-fiber EMG study. Muscle Nerve 1989; 12: 690–694.
- 89 Sandyk R, Gillman MA: Baclofen in hemifacial spasm. Int J Neurosci 1987; 33: 261–264.
- 90 Savino PJ, Sergott RC, Bosley TM, Schatz NJ: Hemifacial spasm treated with botulinum A toxin injection. Arch Ophthalmol 1985; 103: 1305–1306.
- 91 Scheidt CE, Schuller B, Rayki O, Kommerell Deuschl G: Relative absence of psychopathology in benign essential blepharospasm and hemifacial spasm. Neurology 1996; 47: 43–45.
- 92 Seidman MS, Vacharat N: Idiopathic hemifacial spasm treated with alcohol injection: a case report. Ophthalmic Surg 1980; 11: 109–111.
- 93 Sprik C, Wirtschafter JD: Hemifacial spasm due to intracranial tumor. An international survey of botulinum toxin investigators. Ophthalmology 1988; 95: 1042–1045.
- 94 Tash R, DeMerritt J, Sze G, Leslie D: Hemifacial spasm: MR imaging features. AJNR Am J Neuroradiol 1991; 12: 839–842.
- 95 van de Bienzenbos JB, Horstink MW, van de Vlasakker CJ, et al.: A case of bilateral alternating hemifacial spasms. Mov Disord 1992; 7: 68–70.
- 96 Wilkins RH: Hemifacial spasm: a review. Surg Neurol 1991; 36: 251–277.